Characteristics | Values |
---|---|
Age (years) | 44 (24–73) |
 ≤44 | 83 (51.9%) |
 >44 | 77 (48.1%) |
Body mass index (Kg/m2) | 23.0 (16.4–31.6) |
 ≤23.0 | 80 (50.0%) |
 > 23.0 | 80 (50.0%) |
Operation approach | Â |
 Open | 122 (76.3%) |
 Laparoscopy | 38 (23.8%) |
Neoadjuvant chemotherapy | Â |
 No | 105 (65.6%) |
 Yes | 55 (34.4%) |
Ovarian preservation | Â |
 No | 95 (59.4%) |
 Yes | 65 (40.6%) |
Para-aortic lymph node resection | Â |
 No | 90 (56.3%) |
 Yes | 70 (43.8%) |
Histology | Â |
 Squamous | 128 (80.0%) |
 Non-squamous | 32 (20.0%) |
Tumor differentiation | Â |
 Well to moderate | 71 (44.4%) |
 Poorly | 89 (55.6%) |
Stage (FIGO 2009) | Â |
 1B1 | 22 (13.8%) |
 1B2 | 93 (58.2%) |
 2A1 | 27 (16.9%) |
 2A2 | 18 (11.3%) |
Tumor size (cm) | Â |
 ≤2 | 20 (12.5%) |
 2–4 | 84 (52.5%) |
 >4 | 56 (35.0%) |
Depth of invasion | Â |
 Inner layer | 19 (11.9%) |
 Middle layer | 60 (37.5%) |
 Outer layer | 81 (50.6%) |
Vaginal invasion | Â |
 Negative | 114 (71.3%) |
 Positive | 46 (28.8%) |
Lymphovascular space invasion | Â |
 Negative | 43 (26.9%) |
 Positive | 117 (73.1%) |
No. of lymph node resection | 33 (10–98) |
 ≤33 | 84 (52.5%) |
 ≥34 | 76 (47.5%) |
Number of LNM | 2 (1–56) |
 ≤3 | 134 (83.8%) |
 ≥4 | 26 (16.3%) |
Common iliac or para-aortic LNM | Â |
 Negative | 143 (89.4%) |
 Positive | 17 (10.6%) |
Brachytherapy | Â |
 No | 102 (63.8%) |
 Yes | 58 (36.3%) |
Consolidated chemotherapy | Â |
 No | 106 (66.3%) |
 Yes | 54 (33.8%) |
Patterns of recurrence | Â |
 No evidence of disease | 129 (80.6%) |
 Locoregional | 5 (3.1%) |
 Distant and locoregional | 7 (4.4%) |
 Distant | 19 (11.9%) |